Identification, recombinant expression, and characterization of the 100 kDa high molecular weight hymenoptera venom allergens Api m 5 and Ves v 3

Journal of Immunology

Volumn 184, Issue 9, 2010, Pages 5403-5413

  Blank, Simon ^a   Seismann, Henning ^a   Bockisch, Benjamin ^a   Braren, Ingke ^b   Cifuentes, Liliana ^c   McIntyre, Mareike ^c   Rühl, Dana ^a   Ring, Johannes ^c   Bredehorst, Reinhard ^a   Ollert, Markus W ^c   Grunwald, Thomas ^b   Spillner, Edzard ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

^b PLS Design GmbH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

API M 5 ALLERGEN; COMPLEMENTARY DNA; DIPEPTIDYL PEPTIDASE IV; HYMENOPTERA VENOM; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY; RECOMBINANT ALLERGEN; UNCLASSIFIED DRUG; VES V 3 ALLERGEN; ALLERGEN; API M 5 ALLERGEN, APIS MELLIFERA; BEE VENOM; INSECT PROTEIN; RECOMBINANT PROTEIN; VES V 3 ALLERGEN, VESPULA VULGARIS; WASP VENOM;

ARTICLE; BACULOVIRUS; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HONEYBEE; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; AMINO ACID SEQUENCE; ANIMAL; ARMYWORM; BEE; BIOSYNTHESIS; CHEMISTRY; ENZYMOLOGY; GENETICS; IMMUNOLOGY; INSECT BITE; MOLECULAR GENETICS; WASP;

ALLERGENS; AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD26; BEE VENOMS; BEES; HUMANS; IMMUNOGLOBULIN E; INSECT BITES AND STINGS; INSECT PROTEINS; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; SPODOPTERA; WASP VENOMS; WASPS;

EID: 77954481300     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803709     Document Type: Article

References (58)

1. Müller, U. R. 1993. Epidemiology of insect sting allergy. Monogr. Allergy 31: 131-146.
2. Müller, U., A. Helbling, and E. Berchtold. 1992. Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety. J. Allergy Clin. Immunol. 89: 529-535.
3. Ruëff, F., B. Przybilla, U. Müller, and H. Mosbech. 1996. The sting challenge test in Hymenoptera venom allergy. Position paper of the Subcommittee on Insect Venom Allergy of the European Academy of Allergology and Clinical Immunology. Allergy 51: 216-225.
4. Müller, U. R. 2003. Recent developments and future strategies for immunotherapy of insect venom allergy. Curr. Opin. Allergy Clin. Immunol. 3: 299-303.
5. Müller, U. R. 2002. Recombinant Hymenoptera venom allergens. Allergy 57: 570-576.
6. King, T. P., and M. D. Spangfort. 2000. Structure and biology of stinging insect venom allergens. Int. Arch. Allergy Immunol. 123: 99-106.
7. Arbesman, C. E., R. E. Reisman, and J. I. Wypych. 1976. Allergenic potency of bee antigens measured by RAST inhibition. Clin. Allergy 6: 587-595.
8. King, T. P., A. K. Sobotka, L. Kochoumian, and L. M. Lichtenstein. 1976. Allergens of honey bee venom. Arch. Biochem. Biophys. 172: 661-671.
9. Soldatova, L. N., R. Crameri, M. Gmachl, D. M. Kemeny, M. Schmidt, M. Weber, and U. R. Mueller. 1998. Superior biologic activity of the recombinant bee venom allergen hyaluronidase expressed in baculovirus-infected insect cells as compared with Escherichia coli. J. Allergy Clin. Immunol. 101: 691-698.
10. Dudler, T., W. Q. Chen, S. Wang, T. Schneider, R. R. Annand, R. O. Dempcy, R. Crameri, M. Gmachl, M. Suter, and M. H. Gelb. 1992. High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochim. Biophys. Acta 1165: 201-210.
11. Gmachl, M., and G. Kreil. 1993. Bee venom hyaluronidase is homologous to a membrane protein ofmammalian sperm. Proc. Natl. Acad. Sci. USA 90: 3569-3573.
12. Kuchler, K., M. Gmachl, M. J. Sippl, and G. Kreil. 1989. Analysis of the cDNA for phospholipase A2 from honeybee venom glands. The deduced amino acid sequence reveals homology to the corresponding vertebrate enzymes. Eur. J. Biochem. 184: 249-254.
13. Scott, D. L., Z. Otwinowski, M. H. Gelb, and P. B. Sigler. 1990. Crystal structure of bee-venom phospholipase A2 in a complex with a transition-state analogue. Science 250: 1563-1566.
14. Marković-Housley, Z., G. Miglierini, L. Soldatova, P. J. Rizkallah, U. Müller, and T. Schirmer. 2000. Crystal structure of hyaluronidase, a major allergen of bee venom. Structure 8: 1025-1035.
15. Barboni, E., D. M. Kemeny, S. Campos, and C. A. Vernon. 1987. The purification of acid phosphatase from honey bee venom (Apis mellifica). Toxicon 25: 1097-1103.
16. Hoffman, D. R. 1977. Allergens in bee venom. III. Identification of allergen B of bee venom as an acid phosphatase. J. Allergy Clin. Immunol. 59: 364-366.
17. Grunwald, T., B. Bockisch, E. Spillner, J. Ring, R. Bredehorst, and M. W. Ollert. 2006. Molecular cloning and expression in insect cells of honeybee venom allergen acid phosphatase (Api m 3). J. Allergy Clin. Immunol. 117: 848-854.
18. Wood, C. L., and D. R. Hoffman. 1983. Two-dimensional polyacrylamide gel electrophoresis of hymenoptera venom and venom sac extracts. Toxicon 21: 291-299.
19. Hoffman, D. R., W. H. Shipman, and D. Babin. 1977. Allergens in bee venom II. Two new high molecular weight allergenic specificities. J. Allergy Clin. Immunol. 59: 147-153.
20. The Honeybee Genome Sequencing Consortium. 2006. Insights into social insects from the genome of the honeybee Apis mellifera. Nature. 443: 931-949.
21. Ollert, M., S. Weissenbacher, J. Rakoski, and J. Ring. 2005. Allergen-specific IgE measured by a continuous random-access immunoanalyzer: interassay comparison and agreement with skin testing. Clin. Chem. 51: 1241-1249.
22. Eberlein-König, B., C. Schmidt-Leidescher, J. Rakoski, H. Behrendt, and J. Ring. 2006. In vitro basophil activation using CD63 expression in patients with bee and wasp venom allergy. J. Investig. Allergol. Clin. Immunol. 16: 5-10.
23. Ocmant, A., Y. Peignois, S. Mulier, L. Hanssens, A. Michils, and L. Schandené. 2007. Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy. J. Immunol. Methods 320: 40-48.
24. Hauswirth, A. W., S. Natter, M. Ghannadan, Y. Majlesi, G. H. Schernthaner, W. R. Sperr, H. J. Bühring, R. Valenta, and P. Valent. 2002. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J. Allergy Clin. Immunol. 110: 102-109.
25. Erdmann, S. M., B. Sachs, A. Schmidt, H. F. Merk, O. Scheiner, S. Moll-Slodowy, I. Sauer, R. Kwiecien, B. Maderegger, and K. Hoffmann- Sommergruber. 2005. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test. Int. Arch. Allergy Immunol. 136: 230-238.
26. Ausubel, F. M. 1996. Current Protocols in Molecular Biology. Wiley Interscience, New York.
27. Braren, I., S. Blank, H. Seismann, S. Deckers, M. Ollert, T. Grunwald, and E. Spillner. 2007. Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin. Chem. 53: 837-844.
28. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25: 3389-3402.
29. Burge, C. B., and S. Karlin. 1998. Finding the genes in genomic DNA. Curr. Opin. Struct. Biol. 8: 346-354.
30. Bendtsen, J. D., H. Nielsen, G. von Heijne, and S. Brunak. 2004. Improved prediction of signal peptides: SignalP 3.0. J. Mol. Biol. 340: 783-795.
31. Kemeny, D. M., M. G. Harries, L. J. Youlten, M. Mackenzie-Mills, and M. H. Lessof. 1983. Antibodies to purified bee venom proteins and peptides. I. Development of a highly specific RAST for bee venom antigens and its application to bee sting allergy. J. Allergy Clin. Immunol. 71: 505-514.
32. Ring, J., and K. Messmer. 1977. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 309: 466-469.
33. Kettner, A., H. Henry, G. J. Hughes, G. Corradin, and F. Spertini. 1999. IgE and T-cell responses to high-molecular weight allergens from bee venom. Clin. Exp. Allergy 29: 394-401.
34. Hoffman, D. R., and C. L. Wood. 1984. Allergens in Hymenoptera venom XI. Isolation of protein allergens from Vespula maculifrons (yellow jacket) venom. J. Allergy Clin. Immunol. 74: 93-103.
35. Jenkins, N., R. B. Parekh, and D. C. James. 1996. Getting the glycosylation right: implications for the biotechnology industry. Nat. Biotechnol. 14: 975-981.
36. Tretter, V., F. Altmann, V. Kubelka, L. März, and W. M. Becker. 1993. Fucose alpha 1,3-linked to the core region of glycoprotein N-glycans creates an important epitope for IgE from honeybee venom allergic individuals. Int. Arch. Allergy Immunol. 102: 259-266.
37. Kochuyt, A. M., E. M. Van Hoeyveld, and E. A. Stevens. 2005. Prevalence and clinical relevance of specific immunoglobulin E to pollen caused by stinginduced specific immunoglobulin E to cross-reacting carbohydrate determinants in Hymenoptera venoms. Clin. Exp. Allergy 35: 441-447.
38. Hemmer, W., M. Focke, D. Kolarich, I. Dalik, M. Götz, and R. Jarisch. 2004. Identification by immunoblot of venom glycoproteins displaying immunoglobulin E-binding N-glycans as cross-reactive allergens in honeybee and yellow jacket venom. Clin. Exp. Allergy 34: 460-469.
39. Voss, T., E. Ergülen, H. Ahorn, V. Kubelka, K. Sugiyama, I. Maurer-Fogy, and J. Glössl. 1993. Expression of human interferon omega 1 in Sf9 cells. No evidence for complex-type N-linked glycosylation or sialylation. Eur. J. Biochem. 217: 913-919.
40. Staudacher, E., V. Kubelka, and L. März. 1992. Distinct N-glycan fucosylation potentials of three lepidopteran cell lines. Eur. J. Biochem. 207: 987-993.
41. Hancock, K., S. Narang, S. Pattabhi, M. L. Yushak, A. Khan, S. C. Lin, R. Plemons, M. J. Betenbaugh, and V. C. Tsang. 2008. False positive reactivity of recombinant, diagnostic, glycoproteins produced in High Five insect cells: effect of glycosylation. J. Immunol. Methods 330: 130-136.
42. Seismann, H., S. Blank, I. Braren, K. Greunke, L. Cifuentes, T. Grunwald, R. Bredehorst, M. Ollert, and E. Spillner. 2010. Dissecting cross-reactivity in hymenoptera venom allergy by circumvention of alpha-1,3-core fucosylation. Mol Immunol. 47: 799-808.
43. King, T. P., A. Joslyn, and L. Kochoumian. 1985. Antigenic cross-reactivity of venom proteins from hornets, wasps, and yellow jackets. J. Allergy Clin. Immunol. 75: 621-628.
44. Heike, M., U. Möbius, A. Knuth, S. Meuer, and K. H. Meyer zum Büschenfelde. 1988. Tissue distribution of the T cell activation antigen Ta1. Serological, immunohistochemical and biochemical investigations. Clin. Exp. Immunol. 74: 431-434.
45. Mizutani, S., S. Sumi, O. Narita, and Y. Tomoda. 1985. Purification and properties of human placental dipeptidyl peptidase IV. Nippon Sanka Fujinka Gakkai Zasshi 37: 769-775.
46. Nemoto, E., S. Sugawara, H. Takada, S. Shoji, and H. Horiuch. 1999. Increase of CD26/dipeptidyl peptidase IV expression on human gingival fibroblasts upon stimulation with cytokines and bacterial components. Infect. Immun. 67: 6225-6233.
47. Morimoto, C., C. I. Lord, C. Zhang, J. S. Duke-Cohan, N. L. Letvin, and S. F. Schlossman. 1994. Role of CD26/dipeptidyl peptidase IV in human immunodeficiency virus type 1 infection and apoptosis. Proc. Natl. Acad. Sci. USA 91: 9960-9964.
48. Fleischer, B. 1994. CD26: a surface protease involved in T-cell activation. Immunol. Today 15: 180-184.
49. Yaron, A., and F. Naider. 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28: 31-81.
50. Oravecz, T., M. Pall, G. Roderiquez, M. D. Gorrell, M. Ditto, N. Y. Nguyen, R. Boykins, E. Unsworth, and M. A. Norcross. 1997. Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J. Exp. Med. 186: 1865-1872.
51. Cheng, H. C., M. Abdel-Ghany, R. C. Elble, and B. U. Pauli. 1998. Lung endothelial dipeptidyl peptidase IV promotes adhesion and metastasis of rat breast cancer cells via tumor cell surface-associated fibronectin. J. Biol. Chem. 273: 24207-24215.
52. Pethiyagoda, C. L., D. R. Welch, and T. P. Fleming. 2000. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin. Exp. Metastasis 18: 391-400.
53. 2/M checkpoint. Cancer Res. 61: 7204-7210.
54. Wesley, U. V., A. P. Albino, S. Tiwari, and A. N. Houghton. 1999. A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190: 311-322.
55. Tanaka, T., J. S. Duke-Cohan, J. Kameoka, A. Yaron, I. Lee, S. F. Schlossman, and C. Morimoto. 1994. Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV. Proc. Natl. Acad. Sci. USA 91: 3082-3086.
56. Ogawa, Y., Y. Mamura, N. Murayama, and R. Yanoshita. 2006. Characterization and cDNA cloning of dipeptidyl peptidase IV from the venom of Gloydius blomhoffi brevicaudus. Comp. Biochem. Physiol. B Biochem. Mol. Biol. 145: 35-42.
57. Kreil, G., C. Mollay, R. Kaschnitz, L. Haiml, and U. Vilas. 1980. Prepromelittin: specific cleavage of the pre- and the propeptide in vitro. Ann. N. Y. Acad. Sci. 343: 338-346.
58. Biló, B. M., F. Rueff, H. Mosbech, F. Bonifazi, and J. N. Oude-Elberink; EAACI Interest Group on Insect Venom Hypersensitivity. 2005. Diagnosis of Hymenoptera venom allergy. Allergy 60: 1339-1349.